Floatz logo

Fluciclovine

Metastatic Prostate Carcinoma

VA Greater Los Angeles Healthcare SystemradiopharmaceuticalPhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
89/ 100

Competitive context

251 Active assets in the Metastatic Prostate Carcinoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Mayo Clinic
Phase 4BBB
LEUPROLIDE
Mayo Clinic
Phase 4BBB
PREDNISONE TABLETS
Mayo Clinic
Phase 4BB
Abiraterone Acetate
Mayo Clinic
Phase 4BB
Pembrolizumab
CuraCell TX AB
Phase 2BB

View all 50 →

Same molecule, other indications

Fluciclovine is also rated in:

prostate cancerDormant
BB
Indicative ·
71 / 100
View asset →
prostate carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
Male Urogenital DiseasesDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →